-
Solid Biosciences Announces Pricing of Underwritten Offering
-
Form SC 13D/A Solid Biosciences Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13D/A Solid Biosciences Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Solid Biosciences (SLDB) Enters $108.9M Private Placement
-
Solid Biosciences Announces $109 Million Private Placement
-
Form SC 13D/A Solid Biosciences Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Solid Biosciences (SLDB) Announces Closing of Acquisition of AavantiBio and Concurrent $75 Million Private Placement
-
Solid Biosciences Announces Closing of Acquisition of AavantiBio and Concurrent $75 Million Private Placement
-
Form SC 13D/A Solid Biosciences Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Solid Biosciences (SLDB) Announces Acquisition of AavantiBio and Concurrent $75 Million Private Placement
-
Solid Biosciences Announces Acquisition of AavantiBio and Concurrent $75 Million Private Placement
-
Form SC 13D/A Solid Biosciences Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13D/A Solid Biosciences Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13D/A Solid Biosciences Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Solid Biosciences (SLDB) Announces $90 Million Private Placement of Common Stock
-
Solid Biosciences Announces $90 Million Private Placement
-
Solid Biosciences (SLDB) Tops Q2 EPS by 3c
-
Solid Biosciences Reports Second Quarter 2019 Financial Results and Provides Business Update
-
Form SC 13D/A Solid Biosciences Inc. Filed by: RA CAPITAL MANAGEMENT, LLC
-
Solid Biosciences (SLDB) Announces $60 Million Private Placement of Common Stock and Warrants
-
Solid Biosciences Announces $60 Million Private Placement with New and Existing Investors
-
Form SC 13D Solid Biosciences Inc. Filed by: RA CAPITAL MANAGEMENT, LLC

